Clinical Trial Update: Atacicept in Subjects With IgA Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial update for atacicept in IgA nephropathy (Berger disease) showing the study is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Atacicept (atacicept)

Snippet

Sponsor: Vera Therapeutics, Inc. | Conditions: IgA Nephropathy, Berger Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING